{
  "cik": 1808898,
  "cik_padded": "0001808898",
  "entityName": "Benitec Biopharma Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-117604",
      "filed": "2026-03-20",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 18000.0,
        "cash": 97744000.0,
        "eps_diluted": -1.05,
        "free_cash_flow": -23606000.0,
        "net_income": -37917000.0,
        "operating_cash_flow": -23588000.0,
        "operating_income": -41765000.0,
        "stockholders_equity": 97295000.0,
        "total_assets": 99592000.0,
        "total_liabilities": 2297000.0
      },
      "period_end": "2025-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.023608612981139834,
        "roa_avg2y": -0.4995586355910989,
        "roa_period_end": -0.3807233512731946,
        "roe_avg2y": -0.5246466449430274,
        "roe_period_end": -0.38971170152628604
      }
    },
    {
      "accn": "0001193125-26-117604",
      "filed": "2026-03-20",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 179000.0,
        "cash": 50866000.0,
        "eps_diluted": -1.22,
        "free_cash_flow": -19582000.0,
        "net_income": -21751000.0,
        "operating_cash_flow": -19403000.0,
        "operating_income": -22490000.0,
        "stockholders_equity": 47248000.0,
        "total_assets": 52210000.0,
        "total_liabilities": 4962000.0
      },
      "period_end": "2024-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.10502031832035219,
        "roa_avg2y": -0.7675830186681724,
        "roa_period_end": -0.41660601417353,
        "roe_avg2y": -0.9167966280295048,
        "roe_period_end": -0.4603581103962073
      }
    },
    {
      "accn": "0001193125-26-117604",
      "filed": "2026-03-20",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1000.0,
        "cash": 2477000.0,
        "eps_diluted": -14.12,
        "free_cash_flow": -18013000.0,
        "net_income": -19562000.0,
        "operating_cash_flow": -18012000.0,
        "operating_income": -19081000.0,
        "stockholders_equity": 202000.0,
        "total_assets": 4464000.0,
        "total_liabilities": 4262000.0
      },
      "period_end": "2023-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 21.099009900990097,
        "roa_avg2y": -3.7485867586471207,
        "roe_avg2y": -12.686121919584954
      }
    },
    {
      "accn": "0001193125-24-226968",
      "filed": "2024-09-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 13000.0,
        "cash": 4062000.0,
        "eps_diluted": -37.88,
        "free_cash_flow": -15912000.0,
        "net_income": -18208000.0,
        "operating_cash_flow": -15899000.0,
        "operating_income": -17854000.0,
        "stockholders_equity": 2882000.0,
        "total_assets": 5973000.0,
        "total_liabilities": 3091000.0
      },
      "period_end": "2022-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 1.0725190839694656,
        "roa_avg2y": -1.3313834454518865,
        "roe_avg2y": -1.5907740695439454
      }
    },
    {
      "accn": "0001193125-23-239121",
      "filed": "2023-09-21",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 221000.0,
        "cash": 19769000.0,
        "eps_diluted": -3.23,
        "free_cash_flow": -13053000.0,
        "net_income": -13882000.0,
        "operating_cash_flow": -12832000.0,
        "operating_income": -13596000.0,
        "stockholders_equity": 20010000.0,
        "total_assets": 21379000.0,
        "total_liabilities": 1369000.0
      },
      "period_end": "2021-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.06841579210394802,
        "roa_avg2y": -0.8422010556330765,
        "roa_period_end": -0.6493287805790728,
        "roe_avg2y": -0.9178788680243322,
        "roe_period_end": -0.6937531234382809
      }
    },
    {
      "accn": "0001193125-22-237075",
      "filed": "2022-09-02",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 95000.0,
        "cash": 9801000.0,
        "free_cash_flow": -7630000.0,
        "net_income": -8274000.0,
        "operating_cash_flow": -7535000.0,
        "operating_income": -8281000.0,
        "stockholders_equity": 10238000.0,
        "total_assets": 11587000.0,
        "total_liabilities": 1349000.0
      },
      "period_end": "2020-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.13176401640945498,
        "roa_avg2y": -0.5368892349620401,
        "roa_period_end": -0.7140761197894192,
        "roe_avg2y": -0.6167262969588551,
        "roe_period_end": -0.8081656573549522
      }
    },
    {
      "accn": "0001193125-21-276758",
      "filed": "2021-09-20",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 404000.0,
        "cash": 15718000.0,
        "free_cash_flow": 4386000.0,
        "net_income": 2609000.0,
        "operating_cash_flow": 4790000.0,
        "operating_income": 2583000.0,
        "stockholders_equity": 16594000.0,
        "total_assets": 19235000.0,
        "total_liabilities": 2641000.0
      },
      "period_end": "2019-06-30",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.15915391105218754,
        "roa_period_end": 0.13563815960488693,
        "roe_avg2y": 0.17143044878112884,
        "roe_period_end": 0.1572255031939255
      }
    },
    {
      "accn": "0001193125-20-252381",
      "filed": "2020-09-23",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "cash": 11879000.0,
        "stockholders_equity": 13844000.0
      },
      "period_end": "2018-06-30",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-25-211361",
    "filed": "2025-09-22",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001808898.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001808898.json"
  },
  "ticker": "BNTC"
}